The move will also create 12,000 new jobs across the United States, with 6,500 in construction and 1,000 at “new and expanded ...

Following competitor Novartis, pharma giant Roche also announces massive investments in the United States. Swiss jobs and ...

Roche said on Tuesday it would invest $50 billion in the United States over the next five years, creating more than 12,000 ...

The Trump administration’s threat of pharmaceutical tariffs could risk significant political backlash, as the drug industry ...

Roche is committing $50 billion while Regeneron inked a $3 billion manufacturing deal with Fujifilm, allowing the pharma to “nearly double” its U.S. large-scale manufacturing capacity.

Many novel drugs are more relevant for subspecialists, but of the six first-in-class medications approved by the US Food and ...

Roche has pledged to build a giant weight-loss drug factory in the US. The plans form part of a $50bn (£37bn) pledge aimed at ...

Swiss pharmaceuticals powerhouse Roche announced Monday it plans to invest $50 billion in the United States over the next ...

Swiss pharmaceutical giant Roche plans to invest $50 billion in the U.S. over the next five years, the latest major spending commitment by a big drugmaker as the industry faces President Trump's ...

Roche has said it will spend $50bn on manufacturing and research and development in the US, becoming the latest pharmaceutical company to promise greater investment in the face of potential tariffs on ...

Novartis AG NVS, a Swiss pharma giant, is scheduled to report first-quarter 2025 results on April 29, 2025. The Zacks ...

Novartis is set to invest $23 billion in US-based manufacturing and research and development (R&D) over the next five years, ...